David A. Schellenberg

Young Presidents'' Organization (Canada) operates as a non-profit organization. It helps young chief executives to engage, learn, and grow. The company was founded on February 13, 2011 and is headquartered in Toronto, Canada.

The Aerospace Industries Association of Canada (AIAC) is a national organization that promotes and facilitates Canadian competitiveness in the aerospace industry. The non-profit company is based in Ottawa, Canada. The company participates in and coordinate the Canadian industry presence at key international air shows and trade missions each year. AIAC works closely with manufacturers and suppliers to respond to trends in the aerospace industry with innovation, creativity, and leadership. The company represents a diverse group of aerospace companies and organizations in Canada. James Quick has been the CEO of the company since 2011.

Cascade Aerospace Inc. is a dynamic, privately-held Canadian specialty aerospace and defense contractor focused on providing long-term integrated aircraft support programs for Original Equipment Manufacturers (OEMs), military, government and commercial customers.

Conair Group, Inc. is a private company based in Abbotsford, Canada. The Canadian company specializes in manufacturing aircraft.

The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison.

Highland West Capital Ltd. operates as a private equity firm that specializes in management buyouts, acquisitions and debt restructuring investments. The firm prefers to make investments in equity and debt transactions. It typically makes investment in industrial, manufacturing, services and financial business sectors. The company was founded by David James Rowntree and is headquartered in Vancouver, Canada.

The Jim Pattison Foundation provides charity services.

Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada.